Related Experiment Video
Updated: Sep 8, 2025
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.3K
NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression
Qizhi Qin1, Mario Gomez-Salazar1, Robert J Tower2
1Department of Pathology, Johns Hopkins University, Baltimore, Maryland.
Cancer Research
|June 14, 2022
Summary
Neural EGF like-like molecule 1 (NELL1) promotes sarcoma growth and invasion by altering the extracellular matrix. Inhibiting NELL1 reduces tumor progression and metastasis, offering a potential therapeutic strategy for sarcoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sarcomas are cancers characterized by abnormal extracellular matrix (ECM) production.
- Neural EGF like-like molecule 1 (NELL1) is highly expressed in skeletal sarcomas despite nonneoplastic osteoinductive effects.
- NELL1's role in sarcoma progression and its interaction with the ECM is not fully understood.
Purpose of the Study:
- To investigate the role of NELL1 in sarcoma progression, invasion, and metastasis.
- To elucidate the mechanisms by which NELL1 modulates the sarcoma ECM.
- To assess the therapeutic potential of targeting NELL1 in sarcoma.
Main Methods:
- Genetic deletion of NELL1 in human osteosarcoma (OS) cell lines and mouse models.
- Xenograft mouse models to assess tumor progression and metastasis.
- Transcriptomic and phosphoproteomic analyses to identify signaling pathways.
- Analysis of patient data correlating NELL1 expression with survival.
Main Results:
- NELL1 genetic deletion significantly reduced OS cell invasion, tumor progression, metastasis, and improved survival in mouse models.
- NELL1 loss altered the expression of matricellular proteins, leading to reduced FAK signaling.
- Reversing ECM composition in vitro restored NELL1-deficient sarcoma cell phenotypes.
- High NELL1 expression in sarcoma patients correlated with decreased overall survival.
Conclusions:
- NELL1 is a key modulator of the sarcoma ECM, promoting tumor growth, invasion, and metastasis.
- NELL1 orchestrates cell-ECM interactions critical for sarcomagenesis and disease progression.
- Targeting NELL1 signaling represents a potential therapeutic strategy to inhibit sarcoma progression.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.8K
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.2K
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:23Role of Matrix Metalloproteases in Degradation of ECM
2.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:31Osteoclasts in Bone Remodeling
3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
02:55The Nucleolus
9.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K